The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Hong Kong Polytechnic University
About this trial
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Eligibility criteria
Qualifiers
patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
Chinese
Disqualifiers
cognitively impaired
unconscious
refuse to participate
Trial design
Treatments tested in this trial
- Active Control
- Standardized injection protocol
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov